Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
27 Nov 1990 - 11 Dec 1990
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991
Reference Type:
secondary source
Title:
O-Phenylphenol and its Sodium and Potassium Salts: A Toxicological Assessment
Author:
Bomhard, E. M. et al.
Year:
2002
Bibliographic source:
Crit. Rev. Toxicol. 32(6):551-626

Materials and methods

Test guidelineopen allclose all
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: 84/449/EEC (Gazette of the European Community, No. L 251, p. 103) (1984)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Biphenyl-2-ol
EC Number:
201-993-5
EC Name:
Biphenyl-2-ol
Cas Number:
90-43-7
Molecular formula:
C12H10O
IUPAC Name:
2-phenylphenol
Test material form:
solid: crystalline
Details on test material:
Batch No.: Pa. 18
Specific details on test material used for the study:
- Stability under test conditions: Analytic investigations on the stability of the test compound in the vehicle were not carried out for logistic reasons and since there was only a short period of time between preparation and application.
- Storage condition of test material: at room temperature, dry

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Winkelmann, Borchen, Germany
- Age at study initiation: young adult
- Weight at study initiation:229 g (males) and 191 g (females)
- Fasting period before study: no
- Housing: individually in Makrolon Type-II cages on low-dust wood granules (Ssniff, Soest/Westphalia, Germany)
- Diet: fixed formula standard diet Altromin 1324 Pellets (Altrmin GmbH and Co KG, Lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±2
- Humidity (%): 50±10
- Air changes (per hr): approximately 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
other: test substance was worked up into a paste using several drops of Cremophor E (non-ionic organic emulgator)
Details on dermal exposure:
TEST SITE
- Area of exposure: back and flanks
- % coverage: approximately 10% of the body surface
- Type of wrap if used: skin plaster (Fermoflexband, Beiersdorf AG, Germany)

REMOVAL OF TEST SUBSTANCE
- Washing (if done): with luke-warm water
- Time after start of exposure: 24 h

TEST MATERIAL
- Constant volume or concentration used: no (application volume for each animal was based on its body weight just prior to application)
- For solids, paste formed: yes

VEHICLE
- Amount(s) applied (volume or weight with unit): several drops
Duration of exposure:
24 h
Doses:
2000 mg/kg bw (Limit test)
No. of animals per sex per dose:
5
Control animals:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: several times on the day of administration, twice daily thereafter (once daily on weekends and holidays)
- Frequency of weighing: directly before administration (day 1), after 1 week and at study termination
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality occurred throughout the study period.
Clinical signs:
other: There were no test material related signs of systemic toxicity noted throughout the study period. As a local skin change slight reddening was observed in males and females on the day after application, this redness turned to incrustation on day 5 and was
Gross pathology:
There were no test material related changes noted at necropsy.

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
Conclusions:
CLP: not classified